Since pharmacological approaches towards inhibition or modulation of Tau phosphorylation are being pursued for the various kinases [1,20,21,22,23,24], imaging of the kinases in the central nervous system (CNS) will be very valuable, as imaging biomarkers for neurofibrillary tangles (NFT) in AD. This evidence concerns the gene MAPT and Alzheimer disease.